Funct character of GABA_B receptor modulators, drug metabolism, pharmacokinetics
Funct character of GABA_B receptor modulators, drug metabolism, pharmacokinetics
批准号:
8689994
负责人:
Patrick Robert Griffin
金额:
$60.35万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2016-06-30
关键词:
AgonistAnimal ModelAutomobile DrivingBioavailableBiological AssayBiological AvailabilityBiosensorBrainButyric AcidsCalciumCell LineCellsCessation of lifeChemicalsClinicalComputer SimulationComputer softwareCoupledCyclic AMPDataDevelopmentDoseDrug AddictionDrug InteractionsDrug KineticsDrug or chemical Tissue DistributionDrug toxicityDyesEvaluationExposure toGABA AgonistsGABA-B ReceptorGoalsHepaticHourHousingImageIn VitroLaboratoriesLeadLiverMeasuresMethodologyMethodsMonitorNeuronsNicotine DependenceOralPenetrationPharmaceutical ChemistryPharmaceutical PreparationsPharmacologyPhosphorylationPropertyProtocols documentationRattusReaderRecombinantsResearchResearch Project GrantsSeriesSolubilityTestingTherapeutic InterventionTimeTissuesTobacco smokingTriagebasecheminformaticscomputational chemistrycomputerized toolscounterscreencyclic-nucleotide gated ion channelsdrug candidatedrug metabolismfeedinggamma-Aminobutyric Acidin vitro Assayin vivoin vivo Modelnovelpharmacokinetic modelprofessorprogramsreceptorresidencesmall moleculetool
中文摘要
GABA_B受体调节剂的体外功能特征:本研究的重点是发展适合于确定GABA_B受体调节剂效力的新的细胞分析方法,评估高优先级有效调节剂选择性的反筛选,阐明化合物体外药理的功能分析,体外和体内药物代谢筛选,以及快速点击扩展和评估化学空间的化学信息学方法的发展。由MG Finn教授(TSRI La Jolla研究项目的PI)实验室合成的GABA_B受体调节剂将在上述检测中进行表征。具有适当的体外效力和药理作用的化合物将进行溶解性、肝微粒体稳定性和体内药代动力学特性的测试。具有可接受的体外轮廓和足够的体内PK特性的化合物将在Asina Markou教授的实验室(PI)使用体内模型进行评估。迭代化学优化将被采用,并在电子点击扩展方法中补充,从而产生有效的和选择性的GABA_B调节剂。
英文摘要
In vitro functional characterization of GABA_B receptor modulators: The emphasis of this research project is on developing novel cell-based assays suitable to determine potency of GABA_B receptor modulators, counterscreens to assess selectivity of high priority potent modulators, functional assays to elucidate in vitro pharmacology of compounds, in vitro and in vivo drug metabolism screens, and development of cheminformatic approaches for rapid hit expansion and evaluation of chemical space. GABA_B receptor modulators that are synthesized in the laboratory of Professor MG Finn (PI of TSRI La Jolla research project) will be characterized in the aforementioned assays. Compounds with appropriate in vitro potency and pharmacology will be tested for solubility, liver microsomal stability, and in vivo pharmacokinetic properties. Compounds with acceptable in vitro profiles and with adequate in vivo PK properties will be evaluated using in vivo models in Professor Athina Markou's laboratory (PI). Iterative chemical optimization will be employed and supplemented with in silico hit expansion approaches resulting in potent and selective GABA_B modulators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantifying and modeling ligand-dependent control of RORγ dynamics via structural proteomics
-
批准号:10503840
-
项目类别:
-
资助金额:$59.28万
-
财政年份:2022
-
负责人:Patrick Robert Griffin
-
依托单位:
Quantifying and modeling ligand-dependent control of RORγ dynamics via structural proteomics
-
批准号:10704173
-
项目类别:
-
资助金额:$59.28万
-
财政年份:2022
-
负责人:Patrick Robert Griffin
-
依托单位:
PPARG regulates osteocyte bioenergetics and function during aging
-
批准号:10426408
-
项目类别:
-
资助金额:$2.64万
-
财政年份:2021
-
负责人:Patrick Robert Griffin
-
依托单位:
PPARG regulates osteocyte bioenergetics and function during aging
-
批准号:10317378
-
项目类别:
-
资助金额:$67.81万
-
财政年份:2021
-
负责人:Patrick Robert Griffin
-
依托单位:
PPARG regulates osteocyte bioenergetics and function during aging
-
批准号:10634739
-
项目类别:
-
资助金额:$66.56万
-
财政年份:2021
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9926588
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:9899246
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:10357876
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:10115706
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:10581523
-
项目类别:
-
资助金额:$65.02万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
ALDH1a1 Inhibition As A Therapeutic Target In Visceral Adiposity and Type 2 Diabetes
-
批准号:10197108
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2017
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9526730
-
项目类别:
-
资助金额:$62.22万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9764509
-
项目类别:
-
资助金额:$9.05万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9125423
-
项目类别:
-
资助金额:$63.84万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Optimization of RORgamma-specific agonists as immune activators for a new immunotherapy approach for cancer
-
批准号:9244000
-
项目类别:
-
资助金额:$43.92万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Optimization of ERRg-specific ligands as in vivo Chemical Probes
-
批准号:9382901
-
项目类别:
-
资助金额:$39.84万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
Molecular Characterization of Novel Insulin Sensitizers
-
批准号:9087254
-
项目类别:
-
资助金额:$58.27万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
Molecular Characterization of Novel Insulin Sensitizers
-
批准号:8986841
-
项目类别:
-
资助金额:$60.57万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
Development of RORbeta-selective modulators as in vivo probes
-
批准号:9088532
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
HDX and NMR Core
-
批准号:10242903
-
项目类别:
-
资助金额:$104.57万
-
财政年份:2012
-
负责人:Patrick Robert Griffin
-
依托单位:
海外基金